Daniel M Kolansky Selected Research

Homozygous Familial Hypercholesterolemia

1/2015	Long-term clinical results of microsomal triglyceride transfer protein inhibitor use in a patient with homozygous familial hypercholesterolemia.
12/2008	Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia.
1/2007	Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.
3/2005	Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel M Kolansky Research Topics

Disease

6	Heart Arrest (Cardiac Arrest) 11/2015 - 04/2009
5	Myocardial Infarction 12/2021 - 06/2002
5	Cardiovascular Diseases (Cardiovascular Disease) 05/2017 - 12/2005
4	Hemorrhage 12/2021 - 08/2006
4	Homozygous Familial Hypercholesterolemia 01/2015 - 03/2005
4	Hypercholesterolemia 02/2012 - 07/2003
3	Acute Coronary Syndrome 01/2022 - 05/2017
3	Thrombosis (Thrombus) 12/2021 - 08/2006
3	Ischemic Stroke 01/2018 - 03/2008
3	Coma (Comas) 12/2013 - 04/2009
2	Heart Failure 01/2022 - 01/2018
2	Body Weight (Weight, Body) 01/2022 - 01/2007
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2006
2	Insulin Resistance 01/2018 - 05/2017
2	Stroke (Strokes) 01/2018 - 05/2017
2	Transient Ischemic Attack 01/2018 - 05/2017
2	Diabetes Mellitus 01/2018 - 05/2017
2	Hypertension (High Blood Pressure) 01/2018 - 06/2012
2	Unstable Angina 05/2017 - 06/2002
2	ST Elevation Myocardial Infarction 11/2016 - 12/2015
2	Aneurysm (Aneurysms) 06/2014 - 04/2014
2	Coronary Disease (Coronary Heart Disease) 06/2012 - 07/2003
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 02/2012 - 01/2007
2	Thrombocytopenia (Thrombopenia) 09/2010 - 08/2006
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Cardiogenic Shock 12/2021
1	Ischemia 11/2021
1	COVID-19 12/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019
1	Weight Loss (Weight Reduction) 12/2018
1	Weight Gain 01/2018
1	Edema (Dropsy) 01/2018
1	Dyspnea (Shortness of Breath) 01/2018
1	Obesity 01/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2018
1	Atrial Fibrillation 01/2018
1	Right Ventricular Dysfunction 11/2015
1	Post-Cardiac Arrest Syndrome 12/2013
1	Ventricular Fibrillation 06/2012
1	Ventricular Tachycardia 06/2012
1	Cardiac Arrhythmias (Arrythmia) 09/2010
1	Sepsis (Septicemia) 07/2010
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2010
1	Out-of-Hospital Cardiac Arrest 04/2009
1	Atherosclerosis 12/2008
1	Pericardial Effusion 03/2008
1	Cerebral Hemorrhage 03/2008
1	Multiple Myeloma 09/2006
1	Immunoglobulin Light-chain Amyloidosis 09/2006
1	Myocarditis (Carditis) 01/2006

Drug/Important Bio-Agent (IBA)

4	LipidsIBA 01/2015 - 01/2007
3	Prasugrel Hydrochloride FDA Link 01/2022 - 01/2018
3	TicagrelorIBA 01/2022 - 01/2018
3	Pharmaceutical PreparationsIBA 01/2018 - 01/2007
2	Pioglitazone (Actos)FDA Link 01/2018 - 05/2017
2	microsomal triglyceride transfer proteinIBA 01/2015 - 01/2007
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2012 - 07/2003
2	Heparin (Liquaemin)FDA LinkGeneric 09/2010 - 08/2006
2	LDL CholesterolIBA 01/2007 - 07/2003
2	omega-Chloroacetophenone (Mace)IBA 12/2005 - 09/2003
1	Natriuretic PeptidesIBA 01/2022
1	AtrasentanIBA 01/2022
1	Endothelin Receptor AntagonistsIBA 01/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	cangrelorIBA 12/2021
1	Insulin (Novolin)FDA Link 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Everolimus FDA Link 04/2014
1	TroponinIBA 06/2012
1	AntithrombinsIBA 09/2010
1	bivalirudin (Angiomax)FDA Link 09/2010
1	LDL Receptors (LDL Receptor)IBA 12/2008
1	CalciumIBA 12/2008
1	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2008
1	BMS201038IBA 01/2007
1	ApolipoproteinsIBA 01/2007
1	Amyloid (Amyloid Fibrils)IBA 09/2006
1	EnzymesIBA 01/2006

Therapy/Procedure

7	Percutaneous Coronary Intervention 11/2021 - 06/2002
5	Induced Hypothermia 12/2013 - 04/2009
4	Resuscitation 11/2015 - 04/2009
3	Therapeutics 01/2018 - 02/2012
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2007
2	Stents 01/2017 - 04/2014
2	Thrombolytic Therapy 12/2015 - 03/2008
2	Catheters 06/2014 - 07/2010
1	Extracorporeal Membrane Oxygenation 12/2021
1	Ambulatory Care (Outpatient Care) 12/2020
1	Continuous Positive Airway Pressure 12/2018
1	Drug Tapering 01/2018
1	Drug-Eluting Stents 01/2017
1	Patient Care Bundles 06/2012
1	Vascular Surgical Procedures 09/2010
1	Catheter Ablation 09/2010
1	Transjugular Intrahepatic Portasystemic Shunt 07/2010
1	Vascular Closure Devices 03/2010
1	Blood Transfusion (Blood Transfusions) 03/2008